The Human Microbiome in Early Life: Implications to Health and Disease

Author:   Omry Koren, PhD (Azrieli Faculty of Medicine, Bar Ilan University, Israel) ,  Samuli Rautava, MD, PhD (Department of Pediatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland)
Publisher:   Elsevier Science Publishing Co Inc
ISBN:  

9780128180976


Pages:   326
Publication Date:   18 September 2020
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $305.33 Quantity:  
Add to Cart

Share |

The Human Microbiome in Early Life: Implications to Health and Disease


Add your own review!

Overview

Full Product Details

Author:   Omry Koren, PhD (Azrieli Faculty of Medicine, Bar Ilan University, Israel) ,  Samuli Rautava, MD, PhD (Department of Pediatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Weight:   0.520kg
ISBN:  

9780128180976


ISBN 10:   0128180978
Pages:   326
Publication Date:   18 September 2020
Audience:   College/higher education ,  Tertiary & Higher Education
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

I. PREGNANCY AND FETAL LIFE 1. The microbiome in a healthy pregnancy 2. The microbiome and pregnancy complications 3. Microbial signatures of preterm birth 4. Prenatal origins of the infant gut microbiome II. BIRTH - ENTERING THE WORLD DOMINATED BY MICROBES 5. Mode of delivery, the infant microbiome, and the risk of disease 6. Early-life antibiotic exposure, the gut microbiome, and disease in later life 7. The intestinal microbiome of preterm infants III. INFANCY - ESTABLISHMENT OF THE MICROBIOME AND HEALTHY DEVELOPMENT 8. The compositional development of the microbiome in early life 9. Microbes, human milk, and prebiotics 10. The early gut microbiome and the risk of chronic disease IV. MODIFYING EARLY MICROBIAL CONTACT 11. Postbiotics: defining the impact of inactivated microbes and their metabolites on promotion of health 12. Modification of the gut microbiome in an attempt to reduce the risk of child disease: clinical data from prenatal interventions 13. Clinical data from postnatal interventions

Reviews

Author Information

Professor Koren received his PhD from Tel Aviv University and moved on to a postdoc at Cornell University where he was part of the NIH Human Microbiome Project. The Koren lab's research focuses on the microbiome, studying the roles of the trillions of bacteria that reside within each individual. They have a wide variety of research interests including interactions between microbiota and the host in health and in disease states in general and specific interest in the microbiome of pregnancy and infancy. Dr. Samuli Rautava received his MD and PhD in pediatrics from the University of Turku, Finland. After completing a postdoctoral fellowship at the Mucosal Immunology and Biology Research Center at Harvard Medical School and the Massachusetts General Hospital for Children, Dr. Rautava continued his clinical training at the University of Turku and Turku University Hospital, earning specialist degrees in pediatrics and neonatology. He then completed a fellowship at the Hospital for Sick Children in Toronto, Ontario, where he was presented with the Sick Kids Fellow of the Year Award. Currently, Dr. Rautava works as the Head of Neonatology at Helsinki University Hospital and Assistant Professor of Neonatology at the University of Helsinki in Finlandas well as Adjunct Professor of Experimental Pediatrics at the University of Turku. Dr. Rautava’s research efforts focus on the short- and long-term health effects of early microbial contact and the transfer of bacteria from the mother to the infant during fetal life, delivery, and early infancy. Specific areas of interest include the causes of spontaneous preterm birth and the impact of early antibiotic use on infant gut microbiota development and later health. Dr. Rautava conducts clinical trials using probiotics in pregnant and breastfeeding women and preterm infants, complemented with experimental studies in close collaboration with experts in microbiology, immunology, and epigenetics.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List